Pàgina inicial > Resultats de la cerca: scid
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.03 segons.
Articles, 4 registres trobats
Documents de recerca, 1 registres trobats
Articles 4 registres trobats  
1.
19 p, 3.2 MB Hematopoietic cell transplantation in severe combined immunodeficiency : The SCETIDE 2006-2014 European cohort / Lankester, Arjan C. (Pediatric Stem Cell Transplantation Program and Laboratory for Pediatric Immunology. Willem-Alexander Children's Hospital. Leiden University Medical Center) ; Neven, Benedicte (Institut Imagine. INSERM UMR1163. Laboratory of Immunogenetics of Pediatric Autoimmune Diseases) ; Mahlaoui, Nizar (French National Reference Center for Primary Immunodeficiencies (CEREDIH) and European Registry for Stem Cell Transplantation for Primary Immunodeficiencies (SCETIDE). Hôpital Universitaire Necker-Enfants malades. Assistance Publique-Hôpitaux de Paris (AP-HP)) ; von Asmuth, Erik G.J. (Pediatric Stem Cell Transplantation Program and Laboratory for Pediatric Immunology. Willem-Alexander Children's Hospital. Leiden University Medical Center) ; Courteille, Virginie (French National Reference Center for Primary Immunodeficiencies (CEREDIH) and European Registry for Stem Cell Transplantation for Primary Immunodeficiencies (SCETIDE). Hôpital Universitaire Necker-Enfants malades. Assistance Publique-Hôpitaux de Paris (AP-HP)) ; Alligon, Mikael (French National Reference Center for Primary Immunodeficiencies (CEREDIH) and European Registry for Stem Cell Transplantation for Primary Immunodeficiencies (SCETIDE). Hôpital Universitaire Necker-Enfants malades. Assistance Publique-Hôpitaux de Paris (AP-HP)) ; Albert, Michael H. (Dr von Haunersches University Children's Hospital) ; Badell Serra, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Bader, Peter (Department for Children and Adolescents Medicine. Division for Stem Cell Transplantation and Immunology. University Hospital Frankfurt) ; Balashov, Dmitry (Department for Hematopoietic Stem Cell Transplantation. Dmitriy Rogachev National Center for Pediatric Hematology. Oncology and Immunology) ; Beier, Rita (Klinik für Pädiatrische Hämatologie und Onkologie. Hannover Medical School) ; Bertrand, Yves (Institut d'Hématologie et d'Oncologie Pédiatrique. Hospices Civils de Lyon and Université Claude Bernard Lyon 1) ; Blanche, Stephane (Unité d'Immuno-hematologie et Rhumatologie Pédiatrique. Hôpital Universitaire Necker-Enfants Malades. Assistance Publique-Hôpitaux de Paris (AP-HP)) ; Bordon, Victoria (Department of Pediatric Hemato-oncology and Stem Cell Transplant. Ghent University Hospital) ; Bredius, Robert G. (Pediatric Stem Cell Transplantation Program and Laboratory for Pediatric Immunology. Willem-Alexander Children's Hospital. Leiden University Medical Center) ; Cant, Andrew (Translational and Clinical Research Institute. Newcastle University. and the Paediatric Haematopoietic Stem Cell Transplant Unit. Great North Children's Hospital) ; Cavazzana, Marina (Laboratory of Genomic Dynamics in the Immune System. Institut Imagine. INSERM UMR1163) ; Díaz de Heredia, Cristina (Vall d'Hebron Institut d'Oncologia) ; Dogu, Figen (Department of PIA and the BMT Unit. Ankara University) ; Ehlert, Karoline (Department of Pediatric Hematology and Oncology. University of Greifswald) ; Entz-Werle, Natacha (Pediatric Onco-hematology Department-Pediatrics III. University Hospital of Strasbourg) ; Fasth, Anders (Department of Pediatrics. Institute of Clinical Sciences. University of Gothenburg) ; Ferrua, Francesca (Pediatric Immunohematology and Bone Marrow Transplantation Unit and the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget). IRCCS San Raffaele Scientific Institute) ; Ferster, Alina (Department of Hemato-oncology. Hôpital Universitaire des Enfants Reine Fabiola) ; Formankova, Renata (Department of Pediatric Hematology and Oncology. Teaching Hospital Motol. 2nd Medical School. Charles University Motol) ; Friedrich, Wilhelm (Department of Pediatrics. University Medical Center Ulm) ; Gonzalez-Vicent, Marta (Hospital del Niño Jesús. Hematopoietic Stem Cell Transplantation and Cellular Therapy Unit) ; Gozdzik, Jolanta (Department of Clinical Immunology and Transplantation. Jagiellonian University Medical College) ; Güngör, Tayfun (Department of Hematology. Oncology. Immunology. Gene Therapy and Stem Cell Transplantation. and Children's Research Center (CRC). University Children's Hospital) ; Hoenig, Manfred (Department of Pediatrics. University Medical Center Ulm) ; Ikinciogullari, Aydan (Department of PIA and the BMT Unit. Ankara University) ; Kalwak, Krzysztof (Department of Pediatric Hematology. Oncology. and BMT. Wroclaw Medical University) ; Kansoy, Savas (Department of Pediatric Hematology and Oncology. Ege University Hospital) ; Kupesiz, Alphan (Department of Pediatrics. Hematology. and Oncology. Akdeniz University School of Medicine) ; Lanfranchi, Arnalda (Diagnostic Department. Stem Cell Laboratory. Section of Hematology and Blood Coagulation. Clinical Chemistry Laboratory. ASST Spedali Civili) ; Lindemans, Caroline A. (Department of Pediatrics. University Medical Center Utrecht. University of Utrecht) ; Meisel, Roland (Department of Pediatric Oncology. Hematology. and Clinical Immunology. Medical Faculty. Division of Pediatric Stem Cell Therapy. Heinrich-Heine-University) ; Michel, Gerard (Service d'Hématologie Immunologie Oncologie Pédiatrique. CHU La Timone) ; Miranda, Nuno A. A. (BMT Unit. Instituto Português de Oncologia de Lisboa) ; Moraleda, Jose (Hospital Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria) ; Moshous, Despina (Laboratory of Genomic Dynamics in the Immune System. Institut Imagine. INSERM UMR1163) ; Pichler, Herbert (Department of Stem Cell Transplantation. Children's Cancer Institute. St Anna Hospital) ; Rao, Kanchan (Great Ormond Street (GOS) Hospital for Children NHS Foundation Trust and University College London GOS Institute of Child Health) ; Sedlacek, Petr (Department of Pediatric Hematology and Oncology. Teaching Hospital Motol. 2nd Medical School. Charles University Motol) ; Slatter, Mary (Translational and Clinical Research Institute. Newcastle University. and the Paediatric Haematopoietic Stem Cell Transplant Unit. Great North Children's Hospital) ; Soncini, Elena (Pediatric Oncohaematology and BMT Unit. Children's Hospital Brescia) ; Speckmann, Carsten (Department of Pediatric Hematology and Oncology. Center for Pediatrics and Adolescent Medicine. Institute for Immunodeficiency. Center for Chronic Immunodeficiency (CCI). Faculty of Medicine. Medical Center. University of Freiburg) ; Sundin, Mikael (Section of Pediatric Hematology. Immunology. and HCT. Astrid Lindgren Children's Hospital. Karolinska University Hospital. and Division of Pediatrics. CLINTEC. Karolinska Institutet) ; Toren, Amos (Paediatric Hemato-oncology and BMT. Sheba Medical Center) ; Vettenranta, Kim (University of Helsinki and Children's Hospital. University of Helsinki) ; Worth, Austen (Great Ormond Street (GOS) Hospital for Children NHS Foundation Trust and University College London GOS Institute of Child Health) ; Yeşilipek, Mehmet A. (Pediatric Hematology. Oncology. and Pediatric Stem Cell Transplantation Unit. Medicalpark Antalya & Göztepe Hospitals) ; Zecca, Marco (Pediatric Hematology/Oncology. Fondazione IRCCS Policlinico San Matteo) ; Porta, Fulvio (Pediatric Oncohaematology and BMT Unit. Children's Hospital Brescia) ; Schulz, Ansgar (Department of Pediatrics. University Medical Center Ulm) ; Veys, Paul (Great Ormond Street (GOS) Hospital for Children NHS Foundation Trust and University College London GOS Institute of Child Health) ; Fischer, Alain (Université de Paris) ; Gennery, Andrew R. (Translational and Clinical Research Institute. Newcastle University. and the Paediatric Haematopoietic Stem Cell Transplant Unit. Great North Children's Hospital)
Background: Hematopoietic stem cell transplantation (HSCT) represents a curative treatment for patients with severe combined immunodeficiency (SCID), a group of monogenic immune disorders with an otherwise fatal outcome. [...]
2022 - 10.1016/j.jaci.2021.10.017
The Journal of Allergy and Clinical Immunology, Vol. 149 Núm. 5 (may 2022) , p. 1744-1754.e8  
Registre complet - Creative Commons
2.
9 p, 1.2 MB Newborn Screening for SCID. Experience in Spain (Catalonia) / Argudo-Ramírez, Ana (Hospital Clínic i Provincial de Barcelona) ; Martín-Nalda, Andrea (Hospital Universitari Vall d'Hebron) ; González de Aledo-Castillo, Jose Manuel (Hospital Clínic i Provincial de Barcelona) ; López-Galera, Rosa (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Marín-Soria, Jose Luis (Hospital Clínic i Provincial de Barcelona) ; Pajares-García, Sonia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia-Prat, Marina (Hospital Universitari Vall d'Hebron) ; Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rivière, Jacques G.. (Hospital Universitari Vall d'Hebron) ; Quintero, Yania (Hospital Clínic i Provincial de Barcelona) ; Collado, Tatiana (Hospital Clínic i Provincial de Barcelona) ; Ribes i Rubió, Antònia (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; García-Villoria, Judit (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Soler-Palacín, Pere (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Newborn screening (NBS) for severe combined immunodeficiency (SCID) started in Catalonia in January-2017, being the first Spanish and European region to universally include this testing. In Spain, a pilot study with 5000 samples was carried out in Seville in 2014; also, a research project with about 35,000 newborns will be carried out in 2021-2022 in the NBS laboratory of Eastern Andalusia. [...]
2021 - 10.3390/ijns7030046
International Journal of Neonatal Screening, Vol. 7 (july 2021)  
Registre complet - Creative Commons
3.
11 p, 3.2 MB LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy / Pascual-García, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bonfill-Teixidor, Ester (Vall d'Hebron Institut d'Oncologia) ; Planas-Rigol, Ester (Vall d'Hebron Institut d'Oncologia) ; Rubio-Perez, Carlota (Vall d'Hebron Institut d'Oncologia) ; Iurlaro, Raffaella (Vall d'Hebron Institut d'Oncologia) ; Arias, Alexandra (Vall d'Hebron Institut d'Oncologia) ; Cuartas, Isabel (Vall d'Hebron Institut d'Oncologia) ; Sala-Hojman, Ada (Vall d'Hebron Institut d'Oncologia) ; Escudero, Laura (Vall d'Hebron Institut d'Oncologia) ; Martinez-Ricarte, Fran (Universitat Autònoma de Barcelona) ; Huber-Ruano, Isabel (Vall d'Hebron Institut d'Oncologia) ; Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Pedrosa, Leire (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Marques, Carlota (Centro Nacional de Investigaciones Oncológicas) ; Braña, Irene (Vall d'Hebron Institut d'Oncologia) ; Garralda, Elena (Vall d'Hebron Institut d'Oncologia) ; Vieito, María (Vall d'Hebron Institut d'Oncologia) ; Squatrito, Juan (Centro Nacional de Investigaciones Oncológicas) ; Pineda, Estela (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Graus Ribas, Francesc (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Espejo, Carmen (Universitat Autònoma de Barcelona) ; Sahuquillo Barris, Juan (Universitat Autònoma de Barcelona) ; Tabernero, Josep (Universitat Autònoma de Barcelona) ; Seoane Suárez, Joan (Institució Catalana de Recerca i Estudis Avançats)
Cancer response to immunotherapy depends on the infiltration of CD8 T cells and the presence of tumor-associated macrophages within tumors. Still, little is known about the determinants of these factors. [...]
2019 - 10.1038/s41467-019-10369-9
Nature communications, Vol. 10 Núm. 1 (january 2019) , p. 2416  
Registre complet - Creative Commons
4.
11 p, 189.3 KB Evaluación de los trastornos de la personalidad mediante la SCID-II, el TCI-R y el MCMI-II / Garcia Fontanals, Alba (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ; Deus Yela, Juan (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut)
La finalidad de este estudio consiste en valorar qué instrumento autoinformado, entre el MCMI-II y el TCI-R, corrobora con más precisión el diagnóstico establecido previamente mediante la SCID-II. [...]
The aim of this study is to assess which self-reported instrument, wether MCMI-II or TCI-R, corroborates more precisely the previously established diagnosis by means of SCID-II. Cloninger's psychobiological model states that the temperament dimensions are associated with each of the clusters of DSM in a discriminating way. [...]
2010
Cuadernos de medicina psicosomática y psiquiatría de enlace, Núm. 96 (2010) , p. 9-19  
Registre complet -

Documents de recerca 1 registres trobats  
1.
1 p, 11.3 MB Gene therapy for severe combined immunodeficiency disease / Medrano González, Laura ; Surrallés i Calonge, Jordi, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Grau en Genètica [833]  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem